Xi, Yong
Shen, Yaxing
Wu, Donglei
Zhang, Jingtao
Lin, Chengbin
Wang, Lijie
Yu, Chaoqun
Yu, Bentong
Shen, Weiyu
Funding for this research was provided by:
Science and Technology Innovation 2025 Major Project of Ningbo (2019B10039)
Thoracic Cancer Clinical Medical Research Center of Ningbo, China (2021L002)
Article History
Received: 21 April 2022
Accepted: 30 June 2022
First Online: 15 July 2022
Declarations
:
: Studies using human tissues were approved by the Ethics Committees of Ningbo Medical Center Lihuili Hospital, Ningbo University and were performed in accordance with the principles of Declaration of Helsinki. The animal study was approved by the Animal Ethic Review Committees of Ningbo Medical Center Lihuili Hospital, Ningbo University. All animal experiments were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals.
: We have received informed consents from patients with esophageal cancer in this study. All authors give consent for the publication of manuscript in Molecular Cancer.
: The authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper.